- Home
- SCI vs EXEL Comparison
SCI vs EXEL Comparison
Compare SCI & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCI | EXEL |
|---|---|---|
| Founded | 1962 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.7B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SCI | EXEL |
|---|---|---|
| Price | $84.31 | $56.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 21 |
| Target Price | ★ $98.00 | $46.50 |
| AVG Volume (30 Days) | 1.0M | ★ 2.6M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | 7.65 | ★ 57.95 |
| EPS | ★ 1.87 | 1.60 |
| Revenue | ★ $4,309,234,000.00 | $452,477,000.00 |
| Revenue This Year | $4.03 | $13.61 |
| Revenue Next Year | $3.73 | $13.13 |
| P/E Ratio | $45.04 | ★ $34.09 |
| Revenue Growth | ★ 2.93 | N/A |
| 52 Week Low | $68.41 | $33.76 |
| 52 Week High | $90.99 | $57.57 |
Technical Indicators
Market Signals| Indicator | SCI | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 56.48 |
| Support Level | $76.06 | $54.30 |
| Resistance Level | $84.15 | $57.12 |
| Average True Range (ATR) | 1.62 | 1.56 |
| MACD | -0.33 | 0.29 |
| Stochastic Oscillator | 29.01 | 99.82 |
Price Performance
Historical ComparisonAbout SCI Service Corporation International
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, it provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. The company derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.